Reovirus and other oncolytic viruses for the targeted treatment of cancer
- 29 June 2006
- journal article
- review article
- Published by Springer Nature in Targeted Oncology
- Vol. 1 (3) , 130-150
- https://doi.org/10.1007/s11523-006-0026-1
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Dual Therapy of Ovarian Cancer Using Measles Viruses Expressing Carcinoembryonic Antigen and Sodium Iodide SymporterClinical Cancer Research, 2006
- Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell VaccinationClinical Cancer Research, 2004
- Quantitative Imaging of Na/I Symporter Transgene Expression Using Positron Emission Tomography in the Living AnimalMolecular Therapy, 2004
- Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell markerBlood, 2003
- Development of a replication-selective, oncolytic poxvirus for the treatment of human cancersCancer Gene Therapy, 2002
- Reoviruses and the host cellTrends in Microbiology, 2001
- Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigenJournal of Clinical Investigation, 2000
- Mechanism of Suppression of Cell-Mediated Immunity by Measles VirusScience, 1996
- Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.Journal of Clinical Investigation, 1993
- The preferential cytotoxicity of reovirus for certain transformed cell linesArchiv für die gesamte Virusforschung, 1977